Rexford Industrial Realty (REXR)
NYSEReal EstateReit - IndustrialSnapshot 2026-10-30
NYSEReal EstateReit - IndustrialSnapshot 2026-10-30
Research Workspace
Put REXR beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Real Estate is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue is contracting — down about 2% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens weak on capital allocation.
View ManagementExpectations look high — what the market is pricing in runs ahead of what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskREXR’s portfolio realignment through planned asset sales is the central claim, supported by higher 2026 guidance. Third-quarter revenue beat consensus overall, though rental income missed consensus and revenue declined year over year. The company raised 2026 core FFO guidance to $2.41-$2.44 per diluted share. REXR trades at 21× P/E versus the 12× peer median, despite its 27× historical multiple. The market prices in more growth than our forecast, leaving the premium dependent on delivery. Our model puts the next-quarter miss probability near 22%. Peer multiples imply a price about 8% below where it trades; our read remains intact. This read is provisional.
Trailing returns as of 2026-10-30. REXR is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 20 analysts currently covering REXR (as of Oct 2026).
Based on 6 Wall Street analysts offering 12-month price targets for REXR in the last 4 months.
Continue this research
Compare REXR with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| REXR Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Industrial REITs — fair value, gap to price, and forward P/E.
Compare the value case
Put REXR next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Portfolio realignment through planned dispositions of $1.5-$2.0 billion
Reported $1.5B portfolio shift and lower leverage advance dispositions and disciplined capital allocation.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $38.22
The last 12 months of price, then the range of analyst 12-month targets from today’s $38.22.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.

Advances: Increase Core FFO per diluted share
Higher 2026 earnings guidance supports Core FFO growth despite a quarterly revenue miss.

Threatens: Portfolio realignment through planned dispositions of $1.5-$2.0 billion
Mixed signals on portfolio realignment may hinder capital allocation.

Advances: Portfolio realignment through planned dispositions of $1.5-$2.0 billion
Investment in a leaner future aligns with portfolio realignment.

Advances: Portfolio realignment through planned dispositions of $1.5-$2.0 billion
Completion of $1.2 billion sale supports capital allocation goals.

Advances: Portfolio realignment through planned dispositions of $1.5-$2.0 billion
Upgrade based on asset sales supports capital allocation strategy.
